Previous 10 | Next 10 |
Synlogic Presents SYNB8802 for Enteric Hyperoxaluria at the American Institute of Chemical Engineers Conference on Microbiome Engineering CAMBRIDGE, Mass. , Dec. 7, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformat...
Gainers: Sundial Growers (SNDL) +35%, FSD Pharma (HUGE) +32%, Apollo Endosurgery (APEN) +26%, G1 Therapeutics (GTHX) +23%, Oncolytics Biotech (ONCY) +17%.Losers: SCWorx (WORX) -14%, 9 Meters Biopharma (NMTR) -14%, AnPac Bio-Medical Science (ANPC)...
SCWorx (WORX) +100%.Professional Diversity Network (IPDN) +25%.Apex Technology Acquisition (APXT) +20%.Genfit SA (GNFT) +18%.Xinyuan Real Estate (XIN) +17% on Q3 results.Rhythm Pharmaceuticals (RYTM) +16% as FDA OKs it's Imcivree for weight management in obese patients.Shi...
Synlogic to Present at Upcoming Virtual Banking Conference PR Newswire CAMBRIDGE, Mass., Nov. 18, 2020 CAMBRIDGE, Mass. , Nov. 18, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synth...
The following slide deck was published by Synlogic, Inc. in conjunction with their 2020 Q3 earnings call. For further details see: Synlogic, Inc. 2020 Q3 - Results - Earnings Call Presentation
Synlogic, Inc. (SYBX) Q3 2020 Results Earnings Conference Call November 05, 2020, 08:30 AM ET Company Participants Daniel Rosan - Head, Corporate Finance & IR Aoife Brennan - President, CEO and Director Gregg Beloff - Interim CFO, Principal Acounting Officer & Principal Financial Offi...
Hall of Fame Resort & Entertainment (HOFV) +90% on partnership agreement with WaV and Sports Illustrated Studio.Kaixin Auto Holdings (KXIN) +62% on entering into a binding term sheet with Haitaoche Limited.Altus Midstream Company (ALTM) +52% on Q3 results.Upw...
Synlogic (SYBX): Q3 GAAP EPS of -$0.36 beats by $0.10.Cash, equivalents and short-term investments of $102M.Based upon its current operating plan, Synlogic expects to have a projected cash runway into 2022.Shares +11.17% PM.Press Release For further details see: Synlogic EPS b...
Synlogic Reports Third Quarter 2020 Financial Results and Provides Business Update - Synlogic ends 3Q2020 with $102.0 million in cash, cash equivalents and investments supporting projected runway into 2022 - - Phase 2 study of SYNB1618 and Phase 1 study of SYNB8802 initiated...
Synlogic Initiates Phase 1 Study of SYNB8802 for the Treatment of Enteric Hyperoxaluria PR Newswire CAMBRIDGE, Mass., Nov. 4, 2020 CAMBRIDGE, Mass. , Nov. 4, 2020 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the ...
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported financial results for the fourth quarter and full year ending December 31, 2023. The Company...
CAMBRIDGE, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today announced that its Board of Directors (the “Board”) has approved the adoption of a limited dur...
A look at the top 10 most actives in the United States NanoString Technologies Inc. (NSTG) rose 97.9% to $0.23 on volume of 419,200,402 shares Sunworks Inc. (SUNW) rose 87.9% to $0.1022 on volume of 385,386,904 shares Green Giant Inc. (GGE) rose 15.4% to $0.0427 on volume of 208,454,257 s...